Can Caribou Biosciences Inc’s (CRBU) drop of -14.47% in a week be considered a lucky break?

On Friday, Caribou Biosciences Inc (NASDAQ: CRBU) was -3.94% drop from the session before settling in for the closing price of $2.03. A 52-week range for CRBU has been $0.66 – $3.00.

Annual sales at Healthcare sector company slipped by -33.41% over the past five years. When this article was written, the company’s average yearly earnings per share was at 9.52%. With a float of $80.97 million, this company’s outstanding shares have now reached $93.00 million.

Let’s look at the performance matrix of the company that is accounted for 147 employees. In terms of profitability, gross margin is 73.03%, operating margin of -2161.63%, and the pretax margin is -1954.67%.

Caribou Biosciences Inc (CRBU) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Caribou Biosciences Inc stocks. The insider ownership of Caribou Biosciences Inc is 12.94%, while institutional ownership is 50.69%. The most recent insider transaction that took place on Mar 14 ’25, was worth 20,400. In this transaction President and CEO of this company bought 20,000 shares at a rate of $1.02, taking the stock ownership to the 3,369,395 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Legal Officer sold 3,564 for $1.35, making the entire transaction worth $4,811. This insider now owns 443,502 shares in total.

Caribou Biosciences Inc (CRBU) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 9.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.16% during the next five years compared to -33.41% drop over the previous five years of trading.

Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators

You can see what Caribou Biosciences Inc (CRBU) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.28.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.23 in one year’s time.

Technical Analysis of Caribou Biosciences Inc (CRBU)

Caribou Biosciences Inc (NASDAQ: CRBU) saw its 5-day average volume 1.95 million, a positive change from its year-to-date volume of 1.37 million. As of the previous 9 days, the stock’s Stochastic %D was 18.14%.

During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 64.50%, which indicates a significant increase from 32.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2288 in the past 14 days, which was higher than the 0.1172 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.4979, while its 200-day Moving Average is $1.4703. Nevertheless, the first resistance level for the watch stands at $2.0067 in the near term. At $2.0633, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.1367. If the price goes on to break the first support level at $1.8767, it is likely to go to the next support level at $1.8033. The third support level lies at $1.7467 if the price breaches the second support level.

Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats

There are 93,005K outstanding shares of the company, which has a market capitalization of 181.36 million. As of now, sales total 9,990 K while income totals -149,110 K. Its latest quarter income was 2,350 K while its last quarter net income were -39,990 K.